FDA Inspection 1067778 — Sichuan Long March Pharmaceutical Co., Ltd.
The FDA completed an inspection of Sichuan Long March Pharmaceutical Co., Ltd. on Sep 14, 2018 in Leshan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leshan (China)